+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Intravenous Paracetamol"

From
United States MAXIGESIC IV Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States MAXIGESIC IV Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • United States
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Within the context of over-the-counter (OTC) drugs, intravenous paracetamol, also known as acetaminophen, occupies a specialized niche. While paracetamol in oral forms, such as tablets or liquids, is widely available without a prescription and well-used for treating pain and fever, its intravenous counterpart is typically used in clinical settings. Intravenous paracetamol is reserved for administering to patients who are unable to take oral medication, offering a rapid onset of pain relief or fever control. It is commonly utilized in hospitals for postoperative pain management or when precise dosage control is necessary. The distinction between the general OTC products and intravenous formulations is marked by the latter's requirement for medical supervision and administration. Some companies that produce or distribute intravenous paracetamol include Pfizer, which has a portfolio of pharmaceutical products that spans a variety of delivery methods, including intravenous solutions. Baxter International is another player in this market, providing medically essential products, including injectable drugs. Another notable company is Fresenius Kabi, a healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition, which includes intravenous paracetamol in its lineup. Show Less Read more